期刊文献+

触珠蛋白在甲状腺乳头状癌中的表达及临床意义 被引量:4

Expression and significance of haptoglobin mRNA and protein in papillary thyroid carcinoma
原文传递
导出
摘要 目的 探讨甲状腺乳头状癌组织中触珠蛋白(Hp)的表达及意义.方法 采用反转录-聚合酶链反应(RT-PCR)、Western blot技术检测甲状腺乳头状癌组织、结节性甲状腺肿及正常甲状腺组织中Hp mRNA和蛋白的表达.结果 甲状腺乳头状癌组织中Hp mRNA的相对表达量(0.913 ±0.102)明显高于结节性甲状腺肿(0.357±0.009)和正常甲状腺组织(0.296 ±0.008).Hp蛋白在甲状腺乳头状癌组织中的相对表达量为0.892 ±0.122,显著高于结节性甲状腺肿(0.211 ±0.051)和正常甲状腺组织(0.197±0.046,P<0.05),而后两者之间差异无统计学意义(P>0.05).随着TNM分期的增加,Hp mRNA和蛋白表达水平有升高的趋势,但各分期间的表达差异无统计学意义(P>0.05).结论 Hp在甲状腺乳头状癌的发生发展中发挥重要作用. Objective To explore the expression and significance of haptoglobin (Hp) in papillary thyroid carcinoma.Methods Reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting were applied to detect the expression of Hp in 112 cases of papillary thyroid carcinoma,67 cases of benign thyroid node and 50 cases of normal thyroid tissues.Results The relative expression value of Hp mRNA was (0.913 ±0.102) in papillary thyroid carcinoma tissues,which were over-expressed comparing with benign thyroid node (0.357 ± 0.009) and normal thyroid tissue (0.296 ± 0.008) groups (P 〈 0.05).The relative expression value of Hp protein was (0.892 ± 0.122) in papillary thyroid carcinoma tissues,which were up-regulated comparing with benign thyroid node (0.211 ±0.051) and normal thyroid tissue (0.197 ± 0.046) groups (P 〈 0.05).However,there was no statistical significance between benign thyroid node and normal thyroid tissues (P 〉 0.05).In addition,although the level of Hp mRNA increased with the higher clinical stages,there were no statistical significance (P 〉 0.05).Condusion Our results suggested that Hp might play a key role in papillary thyroid carcinoma occurrence.Moreover,findings in the present study also provided evidence for the diagnostic and therapeutic strategies in the treatment of papillary thyroid carcinoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第4期881-882,共2页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金青年基金资助项目(81202112)
关键词 触珠蛋白 甲状腺乳头状癌 Haptoglobin Papillary thyroid carcinoma
  • 相关文献

参考文献5

  • 1Alayash AI, Andersen CB, Moestrup SK, et al. Haptoglobin : the hemo- globin detoxifier in plasma[ J]. Trends Biotechnol,2013,31 ( 1 ) :2-3.
  • 2Varadi C, Mittermayr S, Szekr6nyes X, et al. Analysis of haptoglobin N-glycome alterations in inflammatory and malignant lung diseases by capillary electrophoresis [ J ]. Electrophoresis, 2013,34 ( 16 ) : 2287- 2294.
  • 3Quaye IK. Haptoglobin, inflammation and disease [ J ]. Trans R Soc Trop Med Hyg ,2008,102 ( 8 ) :735-742.
  • 4Fujita K, Shimomura M, Uemura M, et at. Serum fucosylated haptoglo- bin as a novel prognostic biomarker predicting high-Gleason prostate cancer[ J ]. Prostate ,2014,74 ( 10 ) : 1052-1058.
  • 5Lee CC, Ho HC, Lee MS, et al. Expression of haptoglobin predicts re- currence in head and neck squamous cell carcinoma [ J]. Clin Chim Acta,2010,411 (15-16) :1116-1121.

同被引文献34

  • 1廖秋林,张卫云,张宏斌,崔华娟,陈炳旭,张伟,陈晓东.鼻咽癌患者血清sICAM-1和SAA1及HSP70检测临床意义分析[J].中华肿瘤防治杂志,2013,20(2):110-112. 被引量:16
  • 2闫慧娴,谷伟军,杨国庆,黄薇,巴建明,王先令,杜锦,金楠,臧丽.桥本甲状腺炎与甲状腺乳头状癌关系的临床研究[J].中华内分泌代谢杂志,2014,30(4). 被引量:51
  • 3谭丽娜,黄进华.结合珠蛋白的研究进展[J].国际病理科学与临床杂志,2006,26(1):43-47. 被引量:39
  • 4Elisei R, Molinaro E, Agate L, et al. Are the clinical and pathological features of differentiated thyroid carcinoma re- ally changed over the last 35 years study on 4187 patients from asinde Italian institution to answer this question[ J]. J Clin Endoerinol Metab,2010,95(4) :1516-1527.
  • 5Jensen K,Patel A,Hopeda V,et al. Dynamic changes in E- cadherin gene promoter methylation dudng rnetastatic pro- gression in papillary thyroid cancer [ J ]. Exp Therap Med, 2011 ( 3 ) :457-462.
  • 6Chaychi L, Belbruno K, Golding A, et al. Unusual manifes- tation of parathyroid carcinoma in the setting of papillary thyroid cancer [J ). Endocr Pract, 2010,16 ( 4 ) : 664-668.
  • 7Hayashi N,Kitaoka M. Fine. needle aspiration biopsy of the thyroid nodule: uses and limitations [ J]. Nippon Rinsho, 2007,65 ( 11 ) : 2003-2007.
  • 8Lin CI, Whang EE, Donner DB, et al. Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enilances both chemosensitivity and radiosensitivity in papillary thyroid cancer [ J]. Mol Cancer Res, 2009, 7 (10) :1655-1662.
  • 9Kaczka K, Fendler W, Borowiee M, et al. Lymph node me- tastases in papillary thyroid cancer detected by quantitative real-time polymerase chain reaction for thyroglobulin and eytokeratine-19[ J]. Pol J Pathol,2013,64(2) :90-95.
  • 10Park do J,Lim JA, Kim TH, et al. Serum thyroglobulin level measured after thyroxine withdrawal is usefial to predict fur- ther recurrence in whole body scan-negative papillary thy- roid cancer patients after reoperation [J]. Endocr J, 2012, 59(11 ) :1021-1030.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部